ScienceDaily: Top Health News |
Immunotherapy drug bolsters head and neck cancer treatment Posted: 28 Feb 2022 02:08 PM PST |
Scientists discover a new molecular pathway shared by two neurodegenerative disorders Posted: 28 Feb 2022 01:16 PM PST Researchers from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of dementia. ALS and FTD are two neurodegenerative disorders in which many cases are linked by mislocalization of TDP-43, where instead of being primarily located in the nucleus of the cell where genes are activated, it forms aggregates outside the nucleus in multiple neurodegenerative diseases. Rare mutations in the TDP-43 gene are known to cause ALS, but almost all cases of ALS show mislocalization of TDP-43. |
Physical fitness linked to lower risk of Alzheimer’s disease Posted: 28 Feb 2022 09:57 AM PST |
Discovery of an innate immunological memory in the intestine Posted: 28 Feb 2022 09:56 AM PST The innate immune system plays a crucial role in regulating host-microbe interactions, and especially in providing protection against pathogens that invade the mucosa. Using an intestinal infection model, scientists discovered that innate effector cells -- group 3 innate lymphoid cells -- act not only during the early stages of infection but can also be trained to develop an innate form of immunological memory that can protect the host during reinfection. |
How a two-faced molecule can silence problematic genes Posted: 28 Feb 2022 08:44 AM PST Researchers have developed a technology, heteroduplex oligonucleotide (HDO), that silences certain genes whose high expression levels fuel disease. Adding a specific molecular tag allowed them to target the HDO to immune cells called lymphocytes safely and efficiently. Doing so with an HDO specific to a gene called Itga4 improved symptoms in a mouse model of multiple sclerosis, suggesting this technology may be developed to use in human immune disorders. |
Healthy gut microbiome improves success of cancer treatment Posted: 28 Feb 2022 08:44 AM PST |
Your lunchtime walks in the summer could be making you less productive Posted: 28 Feb 2022 08:44 AM PST |
Cholesterol-lowering drugs may slow down metastases Posted: 28 Feb 2022 08:43 AM PST |
Suspending syringe services programs will result in an increase of HIV infections Posted: 28 Feb 2022 08:43 AM PST |
Bark of neem tree may protect against coronavirus variants, study finds Posted: 28 Feb 2022 08:43 AM PST Extract from the bark of the Neem tree may help treat and reduce the spread of coronavirus, according to a new study. The research shows that components of Neem bark may target a wide range of viral proteins, suggesting its potential as an antiviral agent against emerging variants of coronaviruses (including SARS-CoV-2). |
Snail competition leads to fewer parasites that cause schistosomiasis Posted: 28 Feb 2022 08:43 AM PST |
Posted: 28 Feb 2022 08:43 AM PST |
New data analysis tool uncovers important COVID-19 clues Posted: 28 Feb 2022 08:43 AM PST |
Posted: 28 Feb 2022 07:38 AM PST |
Gas flares tied to premature deaths Posted: 28 Feb 2022 07:38 AM PST |
New way viruses trigger autoimmunity discovered Posted: 28 Feb 2022 07:38 AM PST |
When money is tight, 'purchase happiness' is low Posted: 28 Feb 2022 06:55 AM PST |
Antibiotic doesn’t prevent future wheezing in babies hospitalized with RSV Posted: 28 Feb 2022 06:11 AM PST |
Computer drug simulations offer warning about promising diabetes and cancer treatment Posted: 28 Feb 2022 06:11 AM PST |
Posted: 28 Feb 2022 06:11 AM PST |
You are subscribed to email updates from Top Health News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |